research papers
Operator-assisted harvesting of protein crystals using a universal micromanipulation robot
aSquare One Systems Design, Jackson Hole, WY 83002, USA, bBruker Analytical X-ray Systems, Madison, WI 53711, USA, cMolecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA, dHampton Research, Aliso Viejo, CA 92656, USA, and eq.e.d. life science discoveries, Livermore, CA 94551, USA
*Correspondence e-mail: bernhardrupp@sbcglobal.net
High-throughput crystallography has reached a level of automation where complete computer-assisted robotic crystallization pipelines are capable of cocktail preparation, crystallization plate setup, and inspection and interpretation of results. While mounting of crystal pins, data collection and structure solution are highly automated, crystal harvesting and cryocooling remain formidable challenges towards full automation. To address the final frontier in achieving fully automated high-throughput crystallography, the prototype of an anthropomorphic six-axis universal micromanipulation robot (UMR) has been designed and tested; this UMR is capable of operator-assisted harvesting and cryoquenching of protein crystals as small as 10 µm from a variety of 96-well plates. The UMR is equipped with a versatile tool exchanger providing full operational flexibility. Trypsin crystals harvested and cryoquenched using the UMR have yielded a 1.5 Å structure demonstrating the feasibility of robotic protein crystal harvesting.
Keywords: automated crystal harvesting; crystal mounting; cryoprotection; trypsin; protease; benzamidine complex; protamine; intermolecular contacts; crystallization additives.
1. Introduction
Structure-based methods are progressively gaining importance in drug lead discovery and design, and the number of therapeutic drugs developed with major contributions from structure-guided methods is rapidly increasing (Congreve et al., 2006). In particular, automated high-throughput drug target crystallography and associated enabling technologies have contributed significantly towards rational structure-based drug design. Computer-assisted robotic crystallization pipelines are capable of cocktail preparation, crystallization plate setup, and inspection and interpretation of results. The mounting of crystal pins, data collection and structure solution are also highly automated (Karain et al., 2002; Pflugrath, 2004; Snell et al., 2004; Beteva et al., 2006), and more and more beamlines are being equipped with pin mounting robotics (https://smb.slac.stanford.edu/robosync/ ). Numerous pharmaceutical companies have thus implemented powerful crystallography pipelines, capable of screening numerous drug targets and receptor-ligand complexes per day (Blundell et al., 2002; Hosfield et al., 2003; Congreve et al., 2006).
In contrast to the screening-related liquid- and plate-handling tasks, as well as the manipulation of crystals once they are cryoquenched, the actual harvesting of the crystals is still performed with manual tools under a microscope. The effect of this break in the automation pipeline is manifold: in addition to the creation of a process bottleneck, particularly in pharmaceutical receptor-ligand screening and crystallographic fragment screening (Burley, 2004), the critical harvesting operations occur late in the process and are a major source of loss of valuable crystals. Avoiding expensive late-stage failure during harvesting is a major step towards increased process efficiency and cost reduction (Rupp, 2003). Moreover, the physics of cryocooling (Garman, 1999; Nave & Garman, 2005) are still one of the least well understood areas in protein crystallography. To a large degree, the difficulty in exploring cryoprocedures is rooted in the poor reproducibility of skill-dependent manual harvesting. Consistent robotic or robot-assisted harvesting, combined with novel hyperquenching techniques (Warkentin et al., 2006), will thus impact our ability to systematically optimize cryotechniques for faster, more reliable crystal cooling.
In a first stage towards fully automated high-throughput crystallography, we have designed and tested an anthropomorphic six-axis universal micromanipulation robot (UMR) capable of reliably harvesting and cryoquenching protein crystals as small as 10 µm from a variety of 96-well plates. The UMR arm is equipped with a versatile tool exchanger. Tape cutters, harvesting pins with MiTeGen MicroLoops (Thorne et al., 2003), cryoliquid exchange and custom tools provide additional operational flexibility. The current user interface is a simple game-style keyboard layout allowing intuitive manual control. Semi-automated process steps such as tool location, loop approach to crystals, as well as fully automated tape cutting and quenching have been implemented in the prototype. Integrated machine vision and object tracking are in development to achieve minimally supervised automated crystal harvesting.
In a first demonstration of operator-assisted robotic operation, we have harvested and cryoquenched a series of 32 different crystals (lysozyme, concanavalin A, glucose isomerase and bovine trypsin) from 96-well sitting-drop plates (1 µl drops) used in automated crystallization pipelines as well as from 24-well CrysChem plates (2 + 2 µl drops) used for manual sitting-drop setup. A movie showing operator-assisted harvest of a ∼80 µm lysozyme crystal from a 96-well plate is available from https://www.ruppweb.org/cryscam/lysocapture.wmv . A bovine trypsin crystal harvested using the UMR yielded 1.50 Å-resolution data and a well refined structure with an R value of 0.153 and an Rfree of 0.176. To our knowledge, this is the first structure from a crystal that has not been directly manipulated by human operators during harvesting and quenching, and it seems to be among the highest resolution trypsin structures refined from in-house data.
Contributing to the high resolution of our trypsin structure is probably the fact that the crystals were grown under conditions that included additives believed to assist in forming crystal contacts (McPherson & Cudney, 2006). The backbone trace of a fragment presumed to be a salmon protamine peptide is visible in weak electron density intercalated between three symmetry-related trypsin molecules.
2. The universal mounting robot
For a robot to harvest protein crystals successfully, it is essential that it be able to mimic the subtle dexterous motions of a human technician. Furthermore, the robot needs to have motion resolutions at least one order of magnitude finer than the diameter of the smallest crystals it will be required to handle. We determined that a six-axis robot with articulated arm geometry was the best choice for this application. Commercial robots are generally not required to operate in the micrometer realm, so the need for special modifications to this robot's actuators, encoders and mechanical linkages was anticipated. As outlined above, we sought to endow the system with a broad range of operational capabilities by equipping it with an automated tool exchange capability and providing access to a library of task-specific end effectors. A video camera with motorized zoom lens provided the system's operator with a high-resolution image of the work volume within a well. The goal was to create a rugged, in the first development phase tele-operated, robotic work cell capable of efficiently performing the full range of tasks associated with crystal harvesting.
2.1. Concept and design
The design team chose the Stäubli RX60 (Fig. 1) as the core robotic component for this application. This Swiss-made robot has been used successfully in a number of very high-precision applications and was deemed to offer the best combination of payload, reach and resolution. Other than minor modifications made to the transmission linkages at the factory, this was an `off-the-shelf' robot. Initial testing of the robot demonstrated its ability to translate the tip of a standard sample pin with a resolution consistent with the needs of crystal harvesting. Consequently, no further modifications were made to the robot.
Special end effectors were designed to provide for plate handling, tape cutting and crystal harvesting (Fig. 2). In each instance, these designs simply adapted existing manual process tools and provided a means for precisely aligning these tools relative to the robot. Each end effector incorporated kinematic mounting features allowing it to be accurately registered in a storage library at the edge of the work cell. Testing confirmed the system's ability to reliably perform all basic material handling tasks.
Initial tests of the system's ability to harvest crystals were performed using relatively large (∼200 µm) lysozyme crystals grown in a sitting-drop configuration. With some practice, an operator was able to capture these crystals successfully via the robot's keyboard-driven user interface. Tests were performed using both standard nylon loops provided by Hampton Research and etched Kapton loops manufactured by MiTeGen (Thorne et al., 2003). While both types of loops worked, the Kapton loops were easier to manipulate relative to the crystal and allowed the capture sequence to be performed more quickly. In subsequent tests, only Kapton loops were used.
The next sequence of tests verified the system's ability to capture crystals within a variety of sitting-drop wells. As with the hanging-drop experiments, some practice was needed before an operator was able to maneuver the tip of the harvesting loop efficiently within the geometry of a well. However, once these maneuvers were perfected, tele-operated capture was rapid and reliable (Fig. 3). With this success, progressively smaller lysozyme crystals were harvested, culminating in the capture of crystals only 10 µm in diameter. The feasibility of robotic crystal cleaving and other microsurgical operations were also verified.
2.2. Operational tests and system integration
Following successful demonstration of the robot's ability to perform individual process tasks, system-level tests of the UMR were performed. The goal of these tests was to demonstrate the ability of the UMR to seamlessly perform the sequence of tasks required to completely open the bottleneck associated with the crystal harvesting process. Microtiter plates enter the system through an input port, where the robot accepts the tray and presents it to the imaging module. Magnified images of each of the plate's wells are acquired and displayed to the system operator. Once the operator identifies those wells that hold usable crystals, the robot precisely cuts through the tape, acquires the appropriately sized harvesting loop and positions the tip of the loop in the center of the well. The operator then takes direct control of the robot and performs the necessary harvesting and cryoprotecting operations. Finally, the operator returns control back to the robot and the robot automatically cryoquenches the crystal (Fig. 4). During a series of tests with numerous crystals grown in varying plates under different conditions, the feasibility of a tele-operated UMR was established. Ultimately, a of trypsin complexed with benzamidine was refined at 1.5 Å from data collected from a robotically harvested and cryoquenched crystal.
2.3. Future developments
Following the success of the tele-operated harvesting, we will now attempt to expand the functionality of the UMR concept and establish its ability to perform the full range of crystal harvesting tasks autonomously. et al., 2006) will significantly extend the conditions under which crystals can be successfully cryomounted. The system's capability to perform necessary `pedestrian' functions such as plate handling, plate positioning, tape piercing and resealing will also be refined.
of the tele-operated prototype, verification of an appropriately resolved sensory capability (machine vision in this case) and successful conversion of operator-directed robot commands into well defined automated motion routines are the three crucial elements needed to create a self-directed system; we plan to investigate each of these elements systematically. Next, a fully realized UMR with expanded functional capabilities will be built and tested. The primary goal of this phase of the project will be to unite the precision robotics already developed with refined machine vision guidance in order to remove the human operator entirely from the crystal harvesting process. Higher-order micromanipulation devices will also be investigated in an effort to lower the system's crystal capture threshold below 1 µm, which will allow harvesting of even the smallest crystals and added precision in micromanipulation procedures, such as dissecting macroscopically twinned or inter-grown crystals. While crystals smaller than 10 µm are of limited value for routine diffraction (generally requiring data collection on specialized microfocusing beamlines), microcrystals may still be useful for seeding operations. Fluid handling will be incorporated into the UMR allowing the system to apply cryoprotectants to mature crystals and to create protein-ligand complexes. Full support of hyperquenching cryotechniques (WarkentinOne of the most relevant issues for harvesting from small drops (drops in the 100 + 100 µl range are routinely used in robotic setup) is the time needed for harvesting. Tool exchange is very fast (3–5 s) and movement of tools into close proximity of crystals can be performed with high motor speed settings, which will allow the reduction of open well time substantially, while at the same time delicate movements involving crystals can be preformed with great accuracy and consistency. Tool handling is generally very fast and simple for the UMR robot. As a typical example, the change of the harvesting loop from one hand to the other, required by a change in approach position to the well, is difficult even for an ambidextrous operator. For the UMR, only a trivial tool rotation is involved. We think that optimization and automation of numerous steps using the UMR will ultimately minimize harvest times and thus drastically reduce the risk of dried-up crystallization drops before the operation can be completed.
3. Structure of robotically harvested trypsin–benzamidine complex
3.1. Crystallization
Bovine trypsin (60 mg, Sigma Chemicals) was mixed with benzamidine (5 mg, Sigma Chemicals) and dissolved in 1 ml of 0.1 M HEPES buffer at pH 7.0 containing 3 mM CaCl2. The protein–benzamidine complex was then crystallized by sitting-drop vapor diffusion (McPherson & Cudney, 2006) in Cryschem plastic plates (Hampton Research, Aliso Viejo, CA). The sample drops were composed of 2 µl of the protein–benzamidine stock and 2 µl of 15% PEG 3350 in 0.1 M HEPES pH 7.0, also containing 10 mg ml−1 of salmon sperm protamine (Sigma Chemicals). The sample yielded orthorhombic prismatic crystals after about one week at 295 K.
3.2. Robotic harvesting and cryocooling
The sitting-drop plate containing trypsin crystals was loaded into the UMR and positioned relative to the imaging optics. Candidate crystals were identified by the system's operator and robotically harvested as described in §2 using an appropriately sized Kapton loop. Immediately following capture, the crystals were quenched in liquid nitrogen and inserted into a cryostorage puck as depicted in Fig. 4.
3.3. Data collection
Hampton Research CrystalCap pins containing the cryoprotected robotically harvested crystals in MiteGen Kapton loops (Thorne et al., 2003) were directly mounted out of liquid-nitrogen storage pucks using cryo-tongs. Diffraction data of the orthorhombic P212121 crystals were collected in anomalous data collection strategy at 100 K with a Platinum135 CCD detector using Cu Kα radiation from a Bruker MICROSTAR-H rotating-anode generator operating at 2.7 kW. Intensities were integrated and scaled using the PROTEUM software suite (Bruker, 2004). Data collection statistics are summarized in Table 1.
‡Deviations from restraint targets (Engh & Huber, 1991). §Estimated diffraction precision index (DPI) based on Rfree (Cruickshank, 1999). ¶Real-space Fc map against averaged and weighted Shake & wARP map. ††Real-space Fo map against Fc map, as reported by REFMAC5. ‡‡Returned by EDS validation server (Kleywegt et al., 2004) during deposition via autodep (EBI-MSD). §§Regions as defined in PROCHECK (Laskowski et al., 1993). |
3.4. Structure solution and refinement
The processed diffraction data in SCALEPACK (Otwinowski & Minor, 1997) format and the starting model (PDB code 1v2l ) were submitted to the Shake & wARP (SNW) package (Reddy et al., 2003) for rigid-body and generation of multiple-averaged bias minimized SNW maps. Manual adjustment and rebuilding in Xtalview (McRee, 1999) and Coot (Emsley & Cowtan, 2004) was followed by in REFMAC5 (Murshudov et al., 1997). After building of water structure and repeated bias removal using SNW, further features in the electron density could be built. We placed the inhibiting benzamidine in its unambiguous electron density and built phenol molecules, presumably originating from the protamine preparation, in two alternate conformations in corresponding density. At this stage, real-space correlation of the trypsin model was excellent (Fig. 2), Rfree was 18.3, and weak but in large parts contiguous electron density could be detected between neighboring molecules in both SNW and mFo–Dfc maps.
The residual density was approximated as the backbone trace of a peptide, probably resulting from the salmon protamine extract and built as polyglycine. At several Cα positions, adjacent Cβ density was present, but no sequence assignment was possible. Although Rfree dropped to 0.176 after final (R = 0.153), the exact conformation and nature of the peptide remains undetermined. A water molecule in an octahedral environment showed positive difference density and refined to low B values, suggesting a second metal binding site in addition to the constitutive Ca2+ ion in trypsin. A phased anomalous difference map showed a weak peak, and based on bond distances a sodium ion was placed in the density as a probable cation, although partial occupation by other cations cannot be excluded. There were no indications of anisotropy in the electron density maps, and neither TLS nor partial introduction of anisotropic B factors led to significant improvements in Rfree. coordinate r.m.s.d. and geometry statistics are compiled in Table 1. In a final polishing step, all Asn, Gln and His side-chain conformations were checked for chemical plausibility (Weichenberger & Sippl, 2006), and close distance deviations (bumps) of more than 0.2 Å from WHATCHECK targets were corrected (Hoft et al., 1996). Coordinates and structure factors (code 2j9n ) have been deposited with the Protein Data Bank and validated during deposition at EBI-MSD via autodep and the EDS (Kleywegt et al., 2004) service.
3.5. Packing analysis of trypsin
Trypsin is a hardy perennial of protein crystallography, and atomic resolution structures of trypsin, particularly of Fusarium oxysporum (Schmidt et al., 2003), have been used to analyze details of the reaction pathway and molecular movements in the enzyme. Crystals of benzamidine-complexed trypsin (Kd ≃ 20 µM) served as a model in the recently developed radiation-induced phasing (RIP) technique (Nanao et al., 2005). Nearly 260 structures of trypsin from various species, complexed with other inhibitors, and in substrate complexes have been determined (compiled in the REMARK 900 section of PDB entry 2j9n ).
Trypsin is a member of the ubiquitous family of serine endo-petidase, active trypsin cleaves substrates at the C-terminal of Arg and Lys, and catalyzes the cleavage and activation of additional trypsinogen and other pancreatic proenzymes important to protein digestion. The calytic triade in the binding pocket consists of Ser, His and Asp (residues 192, 55 and 99 in our model).
It is secreted by the pancreas as the proenzyme trypsinogen and converted to the active form in the small intestine by enteropeptidase. As an3.5.1. Binding site environment
Comparison with a representative atomic resolution structure (in the orthorhombic P212121 crystal form with cell constants of ∼54, 57 and 66 Å) of bovine trypsin in complex with the competitive inhibitor benzamidine (PDB entry 1j8a ; Cuesta-Seijo & Garcia-Granda, 2002) shows excellent overall agreement (superposition with 0.23 Å overall r.m.s.d.). The binding site contains the benzamidine inhibitor, fully occupied and in a position practically identical to that in other high-resolution structures (Fig. 5). A number of water molecules in the binding site are also conserved, amongst those the W1 water molecule (next to the histidine of the catalytic triade), shown to act as in the cleavage reaction (Schmidt et al., 2003). In the P212121 crystal form typical for trypsin inhibited with the arginine analogue benzamidine, the position of the natural peptide substrates is occupied by a symmetry-related molecule (Fig. 6).
3.5.2. Intercalating density
Of particular interest in our structure are the nature and location of the intermolecular entities connecting three neighboring molecules in the P212121 structure. Bias-minimized SNW electron density maps (Reddy et al., 2003) as well as maximum-likelihood/SigmaA mfo–Dfc (DELFWT) maps created with REFMAC5 (Murshudov et al., 1997) show distinct density fragments, which at lower contour levels of 0.7–0.5σ became contiguous over a large distance equivalent to more than 20 amino acid residues. Given that the main additive in the crystallization cocktail was a salmon protamine extract (SPE), there are several possibilities of which macromolecular entities could be located between the molecules. SPE contains various highly cationic generally basic and arginine rich, as well as other potential components such as polyamines of the spermidine/spermine family. The fact that the electron density, despite the high resolution of the remaining structure, did not show side-chain features distinct enough to allow a clear assignment of residues and directionality seems to indicate that a mixture of in multiple conformations, possibly also polyamines in the region where no side chains can be accommodated, are linking the molecules.
There is in fact precedence for intermolecular contact mediation of protamine et al., 1991). Interestingly, in this insulin structure, a phenol derivative (m-cresol) has also been found to mediate crystal contacts, and phenol has been used to stabilize other insulins (Derewenda et al., 1989). In the absence of a clear assignment, we have modeled our density as a three- and a 16-residue polyglycine backbone (possibly led by an N-terminal lysine residue) as a placeholder for what is probably a mixture of intercalated and other SPE components. Unassigned density that could correspond to the guanidyl groups of arginine in the vicinity of acidic residues and hydrogen-bond acceptors has been observed, but ordered side chains could not be built, probably as a consequence of the substantial entropic loss that would accompany rigid arginine conformations. The averaged B factors (∼70 Å2) of the are accordingly higher than those of surface-exposed trypsin residues (∼16 Å2), indicating partial occupation and/or disorder. To emphasize the tentative assignment, we used the residue name UNK for these in the PDB file.
in crystal structures. Strikingly similar fragments have been located in crystal interfaces of insulin in drug formulations containing the protamine clupeine (BalschmidtDespite the weak density, our intercalated model trace displays features that are compatible with an arginine- and lysine-rich basic peptide; as shown in Fig. 7, the peptide density snakes though the interface between the molecules so that its basic side chains would indeed make contacts with negatively charged patches on the molecules, whereas backbone contacts were generally observed to the polar amide residues of trypsin. LIGPLOT analysis (Wallace et al., 1995) (not shown) of the hydrogen-bond network between trypsin molecules and the backbone of the intercalated peptide verified that the intermolecular contacts involve all three neighboring trypsin molecules.
4. Summary
We have conclusively demonstrated that protein crystals can be successfully harvested and cryoquenched using advanced micromanipulation robotics. Future developments will be targeted towards increasingly autonomous operations with fully integrated real-time machine vision support. Ultimately, the integration of the UMR into robotic protein crystallization pipelines will enable the vision of fully automated protein crystallization platforms as the core of high-throughput crystallography in structural genomics and in pharmaceutical drug target crystallography.
Acknowledgements
This work was sponsored under NIH STTR Phase I grant No. 1 R41 GM073278-01 and by contributions from Square One Systems Design, WY; Bruker AXS, WI; Hampton Research, CA; and q.e.d. life science discoveries, CA. We thank the EBI-MSD deposition team for the careful annotation of PDB entry 2j9n.
References
Abagyan, R., Totrov, M. & Kuznetsov, D. (1994). J. Comput. Chem. 15, 488–506. CrossRef CAS Web of Science Google Scholar
Balschmidt, P., Hansen, F. B., Dodson, E. J., Dodson, G. G. & Korber, F. (1991). Acta Cryst. B47, 975–986. CrossRef CAS Web of Science IUCr Journals Google Scholar
Beteva, A. et al. (2006). Acta Cryst. D62, 1162–1169. Web of Science CrossRef CAS IUCr Journals Google Scholar
Blundell, T. L., Jhoti, H. & Abell, C. (2002). Nat. Rev. Drug Discov. 1, 45–54. Web of Science CrossRef PubMed CAS Google Scholar
Bruker (2004). PROTEUM. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Burley, S. (2004). Modern Drug Discov. 7, 53–56. Google Scholar
Congreve, M., Murray, C. & Blundell, T. (2006). Drug Discov. Today, 10, 895–907. Web of Science CrossRef Google Scholar
Cruickshank, D. W. J. (1999). Acta Cryst. D55, 583–601. Web of Science CrossRef CAS IUCr Journals Google Scholar
Cuesta-Seijo, J. A. & Garcia-Granda, S. (2002). Bol. R. Soc. Hist. Nat. Sec. Geol. 97, 123–131. Google Scholar
Derewenda, U., Derewenda, Z., Dodson, E. J., Dodson, G. G., Reynolds, C. D., Smith, G. D., Sparks, C. & Swenson, D. (1989). Nature (London), 338, 594–596. CrossRef CAS PubMed Web of Science Google Scholar
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132. Web of Science CrossRef CAS IUCr Journals Google Scholar
Engh, R. A. & Huber, R. (1991). Acta Cryst. A47, 392–400. CrossRef CAS Web of Science IUCr Journals Google Scholar
Garman, E. (1999). Acta Cryst. D55, 1641–1653. Web of Science CrossRef CAS IUCr Journals Google Scholar
Helland, R., Otlewski, J., Sundheim, O., Dadlez, M. & Smalas, A. O. (1999). J. Mol. Biol. 287, 923–942. Web of Science CrossRef PubMed CAS Google Scholar
Hoft, R. R. W., Vriend, G., Sander, C. & Albola, E. E. (1996). Nature (London), 381, 272. PubMed Google Scholar
Hosfield, D., Palan, J., Hilgers, M., Scheibe, D., McRee, D. E. & Stevens, R. C. (2003). J. Struct. Biol. 142, 207–217. Web of Science CrossRef PubMed CAS Google Scholar
Karain, W. I., Bourenkov, G. P., Blume, H. & Bartunik, H. D. (2002). Acta Cryst. D58, 1519–1522. Web of Science CrossRef CAS IUCr Journals Google Scholar
Kleywegt, G. J., Harris, M. R., Zou, J.-Y., Taylor, T. C., Wahlby, A. & Jones, T. A. (2004). Acta Cryst. D60, 2240–2249. Web of Science CrossRef CAS IUCr Journals Google Scholar
Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. (1993). J. Appl. Cryst. 26, 283–291. CrossRef CAS Web of Science IUCr Journals Google Scholar
McPherson, A. & Cudney, B. (2006). J. Struct. Biol. 156, 387–406. Web of Science CrossRef PubMed CAS Google Scholar
McRee, D. E. (1999). J. Struct. Biol. 125, 156–165. Web of Science CrossRef PubMed CAS Google Scholar
Merritt, E. A. & Bacon, D. J. (1997). Methods Enzymol. 277, 505–524. CrossRef PubMed CAS Web of Science Google Scholar
Murshudov, G. N., Vagin, A. A. & Dodson, E. D. (1997). Acta Cryst. D53, 240–255. CrossRef CAS Web of Science IUCr Journals Google Scholar
Nanao, M. H., Sheldrick, G. M. & Ravelli, R. B. (2005). Acta Cryst. D61, 1227–1237. Web of Science CrossRef CAS IUCr Journals Google Scholar
Nave, C. & Garman, E. (2005). J. Synchrotron Rad. 12, 257–260. Web of Science CrossRef CAS IUCr Journals Google Scholar
Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 267, 307–326. CrossRef Web of Science Google Scholar
Pflugrath, J. W. (2004). Methods, 34, 415–423. Web of Science CrossRef PubMed CAS Google Scholar
Reddy, V., Swanson, S., Sacchettini, J. C., Kantardjieff, K. A., Segelke, B. & Rupp, B. (2003). Acta Cryst. D59, 2200–2210. Web of Science CrossRef CAS IUCr Journals Google Scholar
Rupp, B. (2003). Acc. Chem. Res. 36, 173–181. Web of Science CrossRef PubMed CAS Google Scholar
Schmidt, A., Jelsch, C., Ostergaard, P., Rypniewski, W. & Lamzin, V. S. (2003). J. Biol. Chem. 278, 43357–43362. Web of Science CrossRef PubMed CAS Google Scholar
Snell, G., Cork, C., Nordmeyer, R., Cornell, E., Meigs, G., Yegian, D., Jaklevic, J., Jin, J., Stevens, R. C. & Earnest, T. E. (2004). Structure, 12, 1–12. Web of Science CrossRef PubMed Google Scholar
Thorne, R. E., Stum, Z., Kmetko, J., O'Neill, K. & Gillilan, R. (2003). J. Appl. Cryst. 36, 1455–1460. Web of Science CrossRef CAS IUCr Journals Google Scholar
Wallace, A. C., Laskowski, R. A. & Thornton, J. M. (1995). Protein Eng. 8, 127–134. CrossRef CAS PubMed Web of Science Google Scholar
Warkentin, M., Berejnov, V., Husseini, N. S. & Thorne, R. E. (2006). J. Appl. Cryst. 39, 805–811. Web of Science CrossRef CAS IUCr Journals Google Scholar
Weichenberger, C. X. & Sippl, M. J. (2006). Structure, 14, 967–972. Web of Science CrossRef PubMed CAS Google Scholar
© International Union of Crystallography. Prior permission is not required to reproduce short quotations, tables and figures from this article, provided the original authors and source are cited. For more information, click here.